Table 10 Treatment outcomes in non-ECMO group vs ECMO group
Variable | All (n = 1491) | Non-ECMO group (n = 1389) | ECMO group (n = 92) | p- value |
|---|---|---|---|---|
Discharge data | ||||
 Microbiological cure (defined as 2 consecutive negative PCR samples for SARS-CoV-2) | 587 (39.4) | 574 (41.3) | 13 (14.1) | 0.000* |
ICU discharge data | ||||
 At 28 days of ICU stay, the patient was | ||||
  Still in ICU, ventilated | 81 (5.4) | 49 (3.5) | 31 (33.7) | 0.000* |
  Still in ICU, not ventilated | 27 (1.8) | 24 (1.7) | 3 (3.3) |  |
  Discharged from ICU | 1310 (87.9) | 1251 (90.1) | 51 (55.4) |  |
Hospital discharge data | ||||
 Transferred to another facility | 99 (6.6) | 89 (6.4) | 10 (10.9) | 0.000* |
 Discharged home alive | 779 (52.3) | 742 (53.4) | 37 (40.2) |  |
 Death | 603 (40.4) | 558 (40.2) | 45 (48.9) |  |
Days of hospitalization | 20.8 ± 18.7 (1–152) | 20.2 ± 18.3 (1–152) | 29.1 ± 20.9 (3–108) | 0.000* |
Days of patient’s stay in ICU | 13.4 ± 13.8 (0–139) | 12.6 ± 13.2 (0–139) | 26 ± 17.1 (3–95) | 0.000* |
Days of mechanical ventilation | 15 ± 16.5 (1–154) | 14.2 ± 16.5 (1–154) | 22.4 ± 14.4 (2–92) | 0.000* |
Days taken to be SARS-CoV-2 PCR-negative | 22.3 ± 12.9 (2–85) | 22.2 ± 13.1 (2–85) | 22.2 ± 11.2 (6–46) | 0.998 |